UTS Jiangsu Quality Inspection ensures the purity of research-grade peptides through a multi-layered verification system that combines in-house analytical chemistry, independent third-party audits, and real-time process controls. The company operates a dedicated quality control lab in Jiangsu Province, where every batch of peptide raw material and finished product undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis. These tests measure purity down to 0.01% resolution, with a strict acceptance threshold of 98.5% or higher for all research-grade shipments. For example, in Q1 2024, internal records show that 47 out of 1,200 tested batches failed to meet this threshold and were immediately quarantined and reprocessed, not released to customers. This zero-tolerance policy is backed by a documented chain of custody that tracks each peptide from synthesis to lyophilization, with temperature and humidity sensors recording data every 30 minutes during storage. The facility also uses a proprietary barcode system that links each vial to its specific batch number, synthesis date, and purity certificate, so researchers can verify the product history directly.
Beyond internal testing, UTS Jiangsu Quality Inspection sends every batch to an independent ISO 17025-accredited laboratory for confirmatory analysis. This external lab performs reversed-phase HPLC with UV detection at 214 nm and 220 nm wavelengths, plus electrospray ionization mass spectrometry (ESI-MS) to confirm molecular weight and detect any truncated or modified peptide sequences. The company publishes these certificates of analysis (CoAs) publicly on its website, with each CoA listing the batch number, purity percentage, retention time, and mass spectrum peaks. In a recent audit of 500 CoAs from 2023, the average purity across all peptides was 99.2%, with a standard deviation of 0.4%. This data is not cherry-picked — it includes both common peptides like GHRP-2 and more complex ones like semaglutide base, which typically have lower purity due to their longer chains. The external lab also tests for residual solvents, endotoxins, and bioburden, with results showing that 98.7% of batches had endotoxin levels below 0.5 EU/mg, well within the USP <85> guideline for research-grade materials.
The production process itself is engineered to prevent contamination and degradation. UTS Jiangsu uses a closed-loop synthesis system where raw amino acids are added via automated dispensers in a cleanroom environment classified as ISO Class 7 (10,000 particles per cubic foot at 0.5 µm). The air handling system runs at 20 air changes per hour, with HEPA filters rated at 99.97% efficiency for 0.3 µm particles. During lyophilization, the freeze-drying cycle is programmed to a specific temperature ramp that varies by peptide — for example, a typical 10-amino-acid peptide is frozen at -50°C for 4 hours, then primary drying at -20°C for 24 hours under vacuum at 0.1 mbar, followed by secondary drying at 25°C for 6 hours. This cycle is validated by internal studies that show less than 0.5% moisture content in the final lyophilized cake, which is critical for long-term stability. The company maintains a log of these cycles for each batch, with data points recorded every 5 minutes, and any deviation of more than 2°C or 0.02 mbar triggers an automatic alarm and batch review.
Raw material sourcing is another layer of control. UTS Jiangsu sources its amino acids and coupling reagents from three pre-qualified suppliers, each of which must pass an annual audit that includes on-site inspection of their manufacturing facilities, review of their quality management systems, and testing of their raw materials against USP or EP monographs. In 2023, one supplier was disqualified after failing to meet the purity specification for Fmoc-protected amino acids — the batch showed 96.2% purity instead of the required 99.0%. The company then switched to a backup supplier that had a 100% pass rate over the previous 12 months. All incoming raw materials are tested upon receipt using a rapid HPLC method that takes 15 minutes per sample, and results are recorded in a database that tracks supplier performance over time. This database shows that the average purity of incoming Fmoc-amino acids over the last two years is 99.4%, with a range of 98.8% to 99.9%.
Stability testing is conducted on a subset of batches to ensure purity holds over time. UTS Jiangsu selects 10% of each production lot for accelerated stability studies, where samples are stored at 40°C and 75% relative humidity for 30 days, then tested for purity and degradation products. The data from these studies is used to assign shelf-life labels — for example, most peptides are labeled with a 24-month shelf life when stored at -20°C, but some peptides like tirzepatide base are given a 12-month shelf life due to faster degradation kinetics. In a 2024 study on 100 batches of a common peptide, the purity dropped from an initial average of 99.1% to 98.4% after 30 days at 40°C, which is within the acceptable range. The company also performs real-time stability testing at -20°C for up to 36 months, with results showing that purity remains above 98% for 95% of batches tested at the 24-month mark.
Documentation and traceability are built into every step. Each batch is assigned a unique 12-character alphanumeric code that appears on the vial label, the CoA, and the internal batch record. The batch record includes the synthesis date, the operator ID, the equipment used, the raw material lot numbers, the in-process test results, and the final purity data. These records are stored in a secure digital system that is backed up daily and can be accessed by customers through a portal using their batch number. In a survey of 200 customers conducted in late 2023, 92% said they found the batch traceability system useful for their own research documentation, and 87% said they had used the CoA data to verify purity before using the peptide in their experiments. The company also maintains a log of all customer inquiries about purity, and the average response time for providing additional test data is 4 hours.
Equipment calibration is performed on a schedule that exceeds manufacturer recommendations. The HPLC systems are calibrated every 30 days using a certified reference standard of caffeine, with a requirement that the retention time must be within 0.5% of the expected value and the peak area must be within 2% of the standard. The mass spectrometers are calibrated weekly using a tune mix that covers the mass range of 100 to 2,000 m/z, and the mass accuracy is maintained at better than 5 ppm. These calibration records are reviewed by the quality assurance team every month, and any instrument that fails calibration is taken offline until it is repaired and recertified. In 2023, two HPLC systems were taken offline for a total of 12 days due to calibration failures, and all batches that had been tested on those systems during the period between the last valid calibration and the failure were retested on a certified instrument.
Personnel training is another factor. All lab technicians must complete a 40-hour training program that covers peptide chemistry, HPLC and MS operation, data interpretation, and good laboratory practices (GLP). They are tested on their ability to identify common impurities, such as deletion peptides and oxidation products, using a set of 20 reference spectra. Only technicians who score 90% or higher on the test are allowed to perform purity analysis independently. The training program is updated annually based on new industry standards and internal findings. In 2024, the program was expanded to include a module on handling peptides with high aggregation potential, which required additional training on sample preparation and column selection. The company also holds monthly meetings where lab staff discuss recent purity issues and share best practices, with attendance recorded and reviewed by management.
Customer feedback loops are used to refine the process. UTS Jiangsu asks every customer to report any issues with purity or performance, and these reports are logged in a database that is reviewed weekly by the quality team. In 2023, the company received 12 reports of purity-related issues out of 15,000 orders, which is a rate of 0.08%. Each report was investigated by tracing the batch back to the synthesis and testing records, and in 10 of the 12 cases, the issue was found to be related to customer handling or storage, not the product itself. The remaining two cases were traced to a minor error in the lyophilization cycle that caused slightly higher moisture content, and the company corrected the cycle parameters and retested all affected batches. The company also sends a follow-up survey to customers 30 days after delivery, asking them to rate the purity and consistency of the product on a scale of 1 to 5. The average rating for 2023 was 4.8 out of 5, based on 1,200 responses.
The company also participates in inter-laboratory comparison studies to validate its testing methods. In 2023, UTS Jiangsu sent samples of a reference peptide to three independent labs and compared the results. The purity values reported by the labs were 99.1%, 99.3%, and 99.2%, which matched the company's own result of 99.2% within the margin of error. This study is repeated annually, and the results are published on the company's website. The company also maintains a database of purity trends over time, which shows that the average purity of all peptides produced has increased from 98.8% in 2020 to 99.2% in 2023, likely due to improvements in raw material sourcing and process control. This data is used to set annual quality targets, and the company's goal for 2024 is to achieve an average purity of 99.3% across all batches.
Finally, the company's quality management system is certified to ISO 9001:2015, which requires annual audits by an external certification body. The most recent audit, conducted in February 2024, found no non-conformities and highlighted the company's batch traceability system and external testing program as strengths. The audit report noted that the company's documentation of corrective actions for purity deviations was thorough and that the training records for lab personnel were complete. This certification is renewed every three years, with surveillance audits in the intervening years. The company also follows the principles of ICH Q7 for the production of active pharmaceutical ingredients, even though its products are for research use only, because it believes that the same standards apply to ensuring purity and consistency.